scienceNov 1, 202459:29pending
Improving Outcomes with First-Line Endocrine-Based Therapy for Patients with HR-Positive, HER2-Negative Metastatic Breast Cancer
About this episode
Prof Francois-Clement Bidard from Institut Curie in Paris and Dr Kevin Kalinsky from Winship Cancer Institute of Emory University in Atlanta discuss improving the outcomes of first-line endocrine-based therapy for patients with HR-positive, HER2-negative metastatic breast cancer.
Get every episode summarized
Each time Breast Cancer Update publishes, we email you a written briefing from the transcript — the topics, who appeared, and any specific claims, with the ad reads skipped.
Email me new episodesFree for 3 shows. No card needed.
Hosts & guests
No transcript yet
This episode has not been transcribed. Request it and it moves to the front of the queue.
More episodes
More from Breast Cancer Update
Breast Cancer — 5-Minute Journal Club Issue 2 with Dr Lajos Pusztai: Current and...
Breast Cancer Update
Mar 18, 202630:21failed
Desmoid Tumors — Microlearning Activity 1 with Dr Ravin Ratan
Breast Cancer Update
Mar 16, 202616:43failed
Antibody-Drug Conjugates for Breast Cancer — Year in Review Series on Relevant N...
Breast Cancer Update
Mar 2, 202658:40pending
Endocrine-Based Therapy for HR-Positive Breast Cancer — Proceedings from a San A...
Breast Cancer Update
Jan 27, 20262:01:07pending